Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Australian Clinical Labs Ltd ( (AU:ACL) ) has shared an update.
Allan Gray Australia Pty Ltd, acting as an investment manager for various funds, has increased its voting power in Australian Clinical Labs Ltd from 6.49% to 7.50% as of May 12, 2025. This change in substantial holding indicates a growing interest and influence in the company, potentially impacting its governance and strategic decisions.
The most recent analyst rating on (AU:ACL) stock is a Buy with a A$4.25 price target. To see the full list of analyst forecasts on Australian Clinical Labs Ltd stock, see the AU:ACL Stock Forecast page.
More about Australian Clinical Labs Ltd
Average Trading Volume: 1,027,281
Technical Sentiment Signal: Sell
Current Market Cap: A$597.1M
For a thorough assessment of ACL stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue